FDA Approves Lumryz for Narcolepsy

THURSDAY, May 4, 2023 -- The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Lumryz is an extended-release formulation of sodium oxybate to be taken...